Answers are grounded in this paper and cite their sources.
Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor that inhibits urokinase. Constitutive and regulated PAI-2 gene expression involves post-transcriptional events, and an AU-rich mRNA instability motif within the 3′-untranslated region of PAI-2 mRNA is required for this process (Maurer, F., Tierney, M., and Medcalf, R. L. (1999)Nucleic Acids Res. 27, 1664–1673). Here we show that instability determinants are present within various exons of the PAI-2 coding region, most notably within exon 4. Deletion of exon 4 from the full-length PAI-2 cDNA results in a doubling in the half-life of PAI-2 mRNA, whereas a 28-nucleotide region within exon 4 contains binding sites for cytoplasmic proteins. Inducible stabilization of PAI-2 mRNA in HT-1080 cells treated with phorbol ester and tumor necrosis factor does not alter the binding of proteins to the exon 4 instability determinant, but resulted in a transient increase in the binding of factors to the AU-rich RNA instability element. Hence, PAI-2 mRNA stability is influenced by elements located within both the coding region and the 3′-untranslated region and that cytoplasmic mRNA binding factors may influence steady state and inducible PAI-2 mRNA expression. Finally a 10-nucleotide region flanking the exon 4 protein-binding site is homologous to instability elements within five other transcripts, suggesting that a common coding region determinant may exist. Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor that inhibits urokinase. Constitutive and regulated PAI-2 gene expression involves post-transcriptional events, and an AU-rich mRNA instability motif within the 3′-untranslated region of PAI-2 mRNA is required for this process (Maurer, F., Tierney, M., and Medcalf, R. L. (1999)Nucleic Acids Res. 27, 1664–1673). Here we show that instability determinants are present within various exons of the PAI-2 coding region, most notably within exon 4. Deletion of exon 4 from the full-length PAI-2 cDNA results in a doubling in the half-life of PAI-2 mRNA, whereas a 28-nucleotide region within exon 4 contains binding sites for cytoplasmic proteins. Inducible stabilization of PAI-2 mRNA in HT-1080 cells treated with phorbol ester and tumor necrosis factor does not alter the binding of proteins to the exon 4 instability determinant, but resulted in a transient increase in the binding of factors to the AU-rich RNA instability element. Hence, PAI-2 mRNA stability is influenced by elements located within both the coding region and the 3′-untranslated region and that cytoplasmic mRNA binding factors may influence steady state and inducible PAI-2 mRNA expression. Finally a 10-nucleotide region flanking the exon 4 protein-binding site is homologous to instability elements within five other transcripts, suggesting that a common coding region determinant may exist. The plasminogen activator system is an important proteolytic cascade that plays a role in the removal of blood clots from the circulation and the turnover of a variety of extracellular matrix proteins (2Collen D. Lijnen H.R. Thromb. Haemostasis. 1995; 74: 167-171Crossref PubMed Scopus (95) Google Scholar). The effector enzyme of this system is the powerful protease plasmin, generated from its inactive precursor plasminogen by the plasminogen activators, namely urokinase- or tissue type plasminogen activator (u-PA1and t-PA). These proteases are themselves regulated by the plasminogen activator inhibitors (PAIs), PAI-1 and PAI-2. PAI-1 effectively inhibits both t-PA and u-PA; however, PAI-2 is widely considered to modulate u-PA activity in the extracellular compartments and plays a less important role in regulating t-PA. Although PAI-2 is found as a secreted glycosylated protein, a more abundant form exists within the cytosolic compartment (3Genton C. Kruithof E.K. Schleuning W.D. J. Cell Biol. 1987; 104: 705-712Crossref PubMed Scopus (125) Google Scholar). The predominant intracellular location of PAI-2 has fueled much speculation about additional functions for this inhibitor. Indeed, growing evidence has indicated a role for PAI-2 in the intracellular events associated with differentiation (4Jensen P.J. Wu Q. Janowitz P. Ando Y. Schechter N.M. Exp. Cell Res. 1995; 217: 65-71Crossref PubMed Scopus (77) Google Scholar), proliferation (5Hibino T. Matsuda Y. Takahashi T. Goetinck P.F. J. Invest. Dermatol. 1999; 112: 85-90Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar), apoptosis (6Dickinson J.L. Norris B.J. Jensen P.H. Antalis T.M. Cell Death Differ. 1998; 5: 163-171Crossref PubMed Scopus (64) Google Scholar), and signal transduction (7Shafren D.R. Gardner J. Mann V.H. Antalis T.M. Suhrbier A. J. Virol. 1999; 73: 7193-7198Crossref PubMed Google Scholar). The gene encoding PAI-2 has generated particular interest, not only for its extracellular and presumed intracellular roles but also because of its impressive regulatory profile. PAI-2 gene transcription rates are markedly increased in response to the tumor promoter phorbol 12-myristate 13-acetate (PMA) (8Schleuning W.D. Medcalf R.L. Hession C. Rothenbuhler R. Shaw A. Kruithof E.K. Mol. Cell. Biol. 1987; 7: 4564-4567Crossref PubMed Scopus (112) Google Scholar) and the phosphatase inhibitor, okadaic acid (9Medcalf R.L. J. Biol. Chem. 1992; 267: 12220-12226Abstract Full Text PDF PubMed Google Scholar). The PAI-2 gene is also one of the most tumor necrosis factor- (TNF) (10Medcalf R.L. Kruithof E.K. Schleuning W.D. J. Exp. Med. 1988; 168: 751-759Crossref PubMed Scopus (91) Google Scholar) and lipopolysaccaride (LPS) (11Schwartz B.S. Monroe M.C. Levin E.G. Blood. 1988; 71: 734-741Crossref PubMed Google Scholar)-responsive genes described. For the latter, this has been further confirmed by serial analysis of gene expression analysis of primary human monocytes, whereby PAI-2 mRNA levels were shown to be increased 105-fold by LPS (12Suzuki T. Hashimoto S. Toyoda N. Nagai S. Yamazaki N. Dong H.Y. Sakai J. Yamashita T. Nukiwa T. Matsushima K. Blood. 2000; 96: 2584-2591Crossref PubMed Google Scholar), being the third most LPS-induced transcript produced in these cells. Notwithstanding the important contribution of transcriptional control of PAI-2 expression (13Dear A.E. Shen Y. Ruegg M. Medcalf R.L. Eur. J. Biochem. 1996; 241: 93-100Crossref PubMed Scopus (24) Google Scholar, 14Antalis T.M. Costelloe E. Muddiman J. Ogbourne S. Donnan K. Blood. 1996; 88: 3686-3697Crossref PubMed Google Scholar), the role of post-transcriptional regulation of the PAI-2 gene has recently been highlighted (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar, 15Maurer F. Medcalf R.L. J. Biol. Chem. 1996; 271: 26074-26080Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar). These investigations stemmed from earlier results whereby treatment of HT-1080 fibrosarcoma cells with a combination of PMA and TNF produced a 50–100-fold increase in PAI-2 gene transcription but a 1500-fold increase in PAI-2 mRNA over a 24-h period (9Medcalf R.L. J. Biol. Chem. 1992; 267: 12220-12226Abstract Full Text PDF PubMed Google Scholar). The discrepancy in the degree of mRNA production was suggestive of inducible stabilization of PAI-2 mRNA under these conditions. Subsequent studies have shown that the rate of PAI-2 mRNA decay can indeed be reduced by phorbol ester (15Maurer F. Medcalf R.L. J. Biol. Chem. 1996; 271: 26074-26080Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar) and dioxin (16Yang J.H. Biochem. Res. 1999; PubMed Scopus Google Scholar) or increased by K. C. J. Cell. PubMed Scopus Google Scholar). studies the of PAI-2 mRNA to the of an AU-rich mRNA determinant (15Maurer F. Medcalf R.L. J. Biol. Chem. 1996; 271: 26074-26080Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar). a binding site for a of cytoplasmic and proteins (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar), an that can the and the N. J. 1998; PubMed Scopus Google Scholar, J. 1998; PubMed Scopus Google Scholar). Although the degree of PAI-2 mRNA instability is influenced by the AU-rich motif in the elements within the coding region and the are also to to the control of PAI-2 mRNA stability the PAI-2 the are (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). Indeed, mRNA stability determinants have been within the coding region of a growing of the of R. 5: PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. 1996; PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. PubMed Scopus Google Scholar), R. A. S. A. PubMed Scopus Google Scholar, D. R. Mol. Cell. Biol. PubMed Scopus Google Scholar, A. Mol. Cell. Biol. 1996; PubMed Google Scholar), factor A. Mol. Biol. Cell. 1999; PubMed Scopus Google Scholar), S. A. S. Mol. Cell. Biol. PubMed Scopus Google Scholar) and Mol. Cell. Biol. 1988; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar). we have exons within the PAI-2 coding region for mRNA instability that the control of PAI-2 mRNA stability is located the coding region, most notably within exon whereas a region within this exon a binding site for cytoplasmic PAI-2 mRNA decay is influenced by both coding region instability elements as as the AU-rich instability in the further is that the region to the of the exon site to mRNA instability elements located within the coding region of five other that a common coding region instability motif may be in mRNA cells were in with 2 and in a with For mRNA decay 4 cells were and for in in in for to with were to Mol. Cell. Biol. PubMed Scopus Google Scholar). Mol. Cell. Biol. PubMed Scopus Google Scholar) was by the human gene under the control of the promoter as as the gene was generated by the from the and (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). or of PAI-2 exons were by the PAI-2 cDNA (8Schleuning W.D. Medcalf R.L. Hession C. Rothenbuhler R. Shaw A. Kruithof E.K. Mol. Cell. Biol. 1987; 7: 4564-4567Crossref PubMed Scopus (112) Google Scholar) as a and sites were the and sites of the to the the The of the exons are indicated in A. The for the are in to or of exons of the PAI-2 within PAI-2 2 2 4 4 type in sites for and to with in a type in sites for and to with for the in transcription of for the RNA were The full-length exon 4 was by from the PAI-2 cDNA and the sites of The of the exon 4 for this is in The exon 4 is also indicated in but site the The of the RNA the exon 4 was by the and of exon and and the and sites of The of these was by The of the for this are in to exon 4 RNA 4 4 4 4 4 4 type in sites for and in a type in sites for and The the full-length PAI-2 cDNA by the promoter has been (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). of exon 4 from the PAI-2 cDNA as a was by the The to exon 4 the PAI-2 exon 4 The to exon 4 was to site in with an site as The the PAI-2 cDNA was confirmed by of cells was by J. T. Scholar) of were in with of and were by RNA was from cells as by and P. N. Biochem. 1987; PubMed Scopus Google Scholar). of of RNA were and to The were with the as R.L. J. 5: PubMed Scopus Google Scholar). were by and to with were a or by a The for were as the cDNA of the full-length PAI-2 cDNA (8Schleuning W.D. Medcalf R.L. Hession C. Rothenbuhler R. Shaw A. Kruithof E.K. Mol. Cell. Biol. 1987; 7: 4564-4567Crossref PubMed Scopus (112) Google the various PAI-2 exons were by as a the cDNA of the human cDNA Mol. Cell. Biol. PubMed Scopus Google the cDNA of S. J.L. J. Mol. Biol. PubMed Scopus Google the cDNA of from The to the PAI-2 exon 4 RNA were For in of was for 2 in the of of inhibitor and of RNA the AU-rich in the were with and RNA was as but of RNA were a in and in RNA were also by in but of The of the were by in the binding were with the for to the was that the was a of over the in the is to the of the RNA over the because of the the in for the cells were by with and for in of cytoplasmic 2 and The were for 4 and the the cytosolic was in and were from as M. Medcalf R.L. Eur. J. Biochem. 1996; PubMed Scopus Google Scholar). were by the For the binding of were with of in a of for of the RNA The was to for and to the a were treated with of for and to a and were by were as (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). of were to the the of the with the RNA and for For the was was as by C. Mol. 2000; PubMed Scopus Google Scholar). were and to the exon RNA that the of PAI-2 exon 4 are in and 4 is in The of these is as and was as a The were to a of or of the to the RNA cytoplasmic and were as in the of RNA proteins to RNA by was as (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar) with the binding of cytoplasmic were with of for and to and were from a and for was to the of and for were to and for in the of being under conditions. were and by For of RNA were in these with the to the of analysis for PAI-2 was as (15Maurer F. Medcalf R.L. J. Biol. Chem. 1996; 271: 26074-26080Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar). of cytoplasmic was to under and a were with for 2 were and with a primary a of and 4 were in and with the for proteins were by the system The mRNA decay system was to mRNA instability determinants within the PAI-2 coding this a of exons or of exons of the PAI-2 coding region were by and the of the gene cells with these were to and the decay rate of was by and by shown in treatment of cells with the produced a transcript that a half-life in of of exon 2 the of mRNA increased the decay rate of the transcript of a exon 2 not alter the decay rate of the These results that exon 2 instability determinants that are by present within exon PAI-2 exons 2 4 were with the half-life of the transcript reduced to less These that exon 4 powerful exons or exons of the transcript and were not as as exons also that within exon or that the instability elements present in exon 4. of exons and the of the a the transcript to an to that produced by exons not these results that instability and stability determinants are located the PAI-2 coding region, with powerful instability elements associated with the of exon 4 and also within exons and this we to the role of exon 4 in the control of PAI-2 mRNA The instability elements within exons and be in a the stability of exon 4 in the exon 4 was the of and the mRNA half-life shown in the in 2 4 were of but with the signal 2 of the mRNA indicated that the half-life of the exon 4 transcript was The that exon 4 in produced instability to the transcript in the of other exons further the that mRNA stability determinants within exons to the of the elements in exon 4. more evidence that within exon 4 a role in PAI-2 mRNA the exon 4 was from the full-length PAI-2 cDNA as a The as as the the full-length PAI-2 cDNA were cells. of were The results of and of both of cells indicated that the mRNA half-life of the PAI-2 transcript to be is in with results (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). the half-life of the PAI-2 transcript was to 2 that of its These that within exon 4 PAI-2 mRNA were to within exon 4 binding sites for this RNA the full-length exon 4 were with cytoplasmic from both cells and HT-1080 fibrosarcoma and binding activity was by HT-1080 cells were in these because these cells the PAI-2 gene and are widely to PAI-2 gene shown in were the exon 4 that the the of these were whereby of RNA of or were to the the as the exon 4 indicated that one of the was indeed with as of this was by of exon 4 RNA but not by RNA cells produced results not further the binding region within the exon 4 a of was RNA RNA the exon 4 were generated and and in a cytoplasmic proteins from HT-1080 cells. shown in the of exon 4 produced RNA confirmed that the to as and were as only the RNA for binding was not by RNA the and region of exon 4 or by RNA of binding of cytoplasmic proteins was to the or not further that the of exon 4 the protein-binding were the full-length exon 4 as a produced the full-length exon 4 were by the RNA but not by or not more the binding sites for the proteins that to the of exon an was as by C. Mol. 2000; PubMed Scopus Google Scholar). this within the RNA were to to the RNA the of the shown in the of and was not by to the 2 only the whereas the 4 also and was as as a of binding activity a of and 4 to the of the these that these for the of and to of the PAI-2 cDNA the by Schleuning (8Schleuning W.D. Medcalf R.L. Hession C. Rothenbuhler R. Shaw A. Kruithof E.K. Mol. Cell. Biol. 1987; 7: 4564-4567Crossref PubMed Scopus (112) Google the of the proteins binding to exon and studies were the RNA HT-1080 cytoplasmic were with the RNA and a with shown in proteins by were that with an of the of the binding to the RNA of the to the and RNA to the of exon 4 exon were as indicated in the the of the proteins was by of the but not by the PAI-2 mRNA stability in HT-1080 cells is regulated by PMA and TNF and these HT-1080 cells were treated with PMA TNF for various to and in PAI-2 mRNA and levels were by and shown in PAI-2 mRNA levels were markedly increased by PMA TNF with an increase in levels 2 and levels analysis of cytoplasmic from the cells further the increase in PAI-2 as a of this were to the of PAI-2 mRNA by PMA TNF be with in the binding or of proteins with PAI-2 mRNA instability this were RNA for the and the region within the PAI-2 that contains the AU-rich instability motif and cytoplasmic from cells treated with PMA TNF for or The AU-rich motif in the is to PAI-2 mRNA instability and to a binding site for factors (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). shown in PMA TNF treatment not alter the of of the with the a transient increase in the of one of the with the AU-rich motif was PMA TNF treatment was only under but was increased and to levels of treatment was from of HT-1080 cells treated with PMA The protein, is to the AU-rich instability in the confirmed in this is associated with the with the AU-rich RNA as the of the indicated with The of the however, to be increased by treatment with these but this was not a inducible stabilization of PAI-2 mRNA by PMA TNF is associated with a transient increase in the binding activity of cytoplasmic proteins to the AU-rich instability in the of PAI-2 The with exon 4 to be is to that a degree of exists a region that and the protein-binding site in exon with within the of R. A. S. A. PubMed Scopus Google Scholar, D. R. Mol. Cell. Biol. PubMed Scopus Google Scholar, A. Mol. Cell. Biol. 1996; PubMed Google Scholar), R. 5: PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. 1996; PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. PubMed Scopus Google Scholar), S. A. S. Mol. Cell. Biol. PubMed Scopus Google Scholar), A. Mol. Biol. Cell. 1999; PubMed Scopus Google Scholar), and R. L. 1988; Google Scholar) For and this of also within or binding sites for proteins associated with mRNA The region of with is found within a region of mRNA instability determinant that is to a protein-binding site A. Mol. Cell. Biol. 1996; PubMed Google Scholar) in The region of with mRNA also a protein-binding site for the coding region determinant binding C. Mol. 2000; PubMed Scopus Google Scholar) exists within the and of this also with the of the instability region of the transcript that a binding site for a S. A. S. Mol. Cell. Biol. PubMed Scopus Google Scholar, S. S. Biochem. 1998; PubMed Scopus Google Scholar). Although mRNA instability determinants the transcript A. Mol. Biol. Cell. 1999; PubMed Scopus Google Scholar), protein-binding sites have been the region of of the PAI-2 exon 4 motif with the mRNA within the site for exons and of the gene M. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar) with in The of found within the transcript is found within a of the coding region that is associated with mRNA instability R. L. 1988; Google Scholar). additional are also found in this and is to that is in of these to the PAI-2 the is The of a homologous motif within the coding region of transcripts, of coding region instability that a common coding region plays a role in the regulation of mRNA PAI-2 is an regulated serine protease inhibitor. in have that the PAI-2 gene is increased in by TNF and Although earlier studies the transcriptional the of the PAI-2 is that the post-transcriptional events PAI-2 expression are Indeed, post-transcriptional for most of the increase in PAI-2 expression in response to TNF and PMA treatment in HT-1080 cells (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar, 15Maurer F. Medcalf R.L. J. Biol. Chem. 1996; 271: 26074-26080Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar). PAI-2 mRNA is a half-life of and of this instability is to an AU-rich located within the that a binding site for is in have the post-transcriptional regulation of the PAI-2 gene and the of within the coding region of PAI-2 elements within the PAI-2 transcript were to the PAI-2 transcript was in the of the (1Maurer F. Tierney M. Medcalf R.L. Nucleic Acids Res. 1999; 27: 1664-1673Crossref PubMed Scopus (63) Google Scholar). the mRNA stability we have been to that exons or of exons of the PAI-2 gene of instability to the suggesting that instability elements within PAI-2 mRNA, exons and the role of exon 4 in the regulation of PAI-2 mRNA stability as this exon the most the the half-life of the transcript to elements within exons and were not further in this present further evidence for a role of within exon 4 in the regulation of PAI-2 mRNA an of exon 4 resulted in a doubling of the PAI-2 mRNA Although this evidence is we the that the removal of an exon the of PAI-2 mRNA in a as to the half-life of the PAI-2 and studies have the protein-binding site to a region within exon 4 of the PAI-2 be to the decay rate of the PAI-2 transcript that a of within this particular and that with an of are cytoplasmic are with RNA the of exon 4. The of this and role in the of mRNA instability to be PAI-2 mRNA is markedly in HT-1080 cells treated with TNF or increase for about of this suggesting that the of PAI-2 under these is we evidence to that the binding of factors to the exon 4 instability was by treatment with these we a transient increase in the binding activity of an inducible of cytoplasmic that the AU-rich motif in the evidence that these proteins a role in PAI-2 mRNA with PMA The of these and a more of role in inducible regulation of PAI-2 mRNA further the only to the AU-rich in the is Although in the a of is present in the of HT-1080 we evidence that the binding activity of treatment of cells with PMA The the coding region mRNA instability determinants in post-transcriptional regulation is the for Cell. 1987; Full Text PDF PubMed Scopus Google Scholar, Mol. Cell. Biol. 1988; PubMed Scopus Google Scholar), R. L. 1988; Google Scholar), R. 5: PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. 1996; PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. PubMed Scopus Google Scholar), R. A. S. A. PubMed Scopus Google Scholar, D. R. Mol. Cell. Biol. PubMed Scopus Google Scholar, A. Mol. Cell. Biol. 1996; PubMed Google Scholar), factor A. Mol. Biol. Cell. 1999; PubMed Scopus Google Scholar), S. A. S. Mol. Cell. Biol. PubMed Scopus Google Scholar, S. S. Biochem. 1998; PubMed Scopus Google Scholar) and Mol. Cell. Biol. 1988; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar) coding region instability of these binding sites for The by these coding region mRNA determinants influence mRNA decay is one of the coding region instability determinants is found in the transcript R. 5: PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. 1996; PubMed Scopus Google Scholar, N.M. Mol. Cell. Biol. PubMed Scopus Google Scholar, J. 1992; PubMed Scopus Google Scholar). this a to a region within the of the coding region C. Mol. 2000; PubMed Scopus Google Scholar, J. 1992; PubMed Scopus Google Scholar, P. J. PubMed Scopus Google Scholar) that is to the coding region determinant from a P. M. N. T. Nucleic Acids Res. 1996; PubMed Scopus Google P.F. J. Nucleic Acids Res. 1998; PubMed Scopus Google Scholar). of the to this was by a that to of the was however, that the binding region may these R. A. S. A. PubMed Scopus Google Scholar). The gene also contains a instability determinant within its coding region R. A. S. A. PubMed Scopus Google Scholar, D. R. Mol. Cell. Biol. PubMed Scopus Google Scholar), and within this determinant have been to a for an A. Mol. Cell. Biol. 1996; PubMed Google Scholar). The mRNA contains a instability determinant with the coding region S. A. S. Mol. Cell. Biol. PubMed Scopus Google Scholar) that a binding site for a S. S. Biochem. 1998; PubMed Scopus Google Scholar). a degree of a region within exon 4 with the of in five other as and region is also in the PAI-2 mRNA a common coding region motif may a role in the control of mRNA this region a binding site for a common factor binding of proteins to sites to be are to the homologous within the influence the binding of proteins to the PAI-2 exon we for the an mRNA instability determinant within exon 4 of the PAI-2 mRNA that a binding site for factors with an of these we that both the PAI-2 exon 4 instability and the AU-rich in the a role in PAI-2 mRNA under conditions. a in the of proteins binding to the AU-rich motif treatment with PMA TNF suggesting that these proteins a role inducible PAI-2 mRNA the region and the exon site is homologous to coding region instability determinants of five other transcripts, suggesting the of a common that may a role in the post-transcriptional regulation of plasminogen activator plasminogen activator plasminogen activator inhibitor type 2 region phorbol 12-myristate 13-acetate tumor necrosis factor lipopolysaccaride human RNA factor coding region
No takes yet. Share an insight, caveat, or question.
Tierney et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: